Amylyx Pharmaceuticals (NASDAQ:AMLX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.82) by 20.73 percent. The company reported quarterly sales of $21.89 million which beat the analyst consensus estimate of $4.72 million by 363.67 percent.
Why Uniti Group Shares Are Trading Lower
Uniti Group shares are trading lower by 11.2% during Monday's session. The company announced plans for a $300 million offering.